While neuroprotective effects of VEGF-A have been identified, administering VEGF-A at high levels may lead to unwanted side effects such as an increase in vessel density [27] and cerebral edema [28], due to its angiogenic activity. This evidence concerns the gene VEGFA and cerebritis.